학술논문

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study
Document Type
Article
Source
In: Cancer. (Cancer, 15 July 2013, 119(14):2555-2563)
Subject
Language
English
ISSN
0008543X
10970142